Overview

Cardiac Power Output in Cardiogenic Shock Patients

Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine whether differences in myocardial reserve predict clinical outcomes for heart failure patients.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Chicago
Treatments:
Dobutamine
Milrinone